Search Results
Test Catalog
DYS2 - Overview: Dysautonomia, Autoimmune/Paraneoplastic Evaluation, Serum
Investigating idiopathic dysautonomic symptoms Directing a focused search for cancer in patients with idiopathic dysautonomia Investigating autonomic symptoms that appear in the course or wake of cancer therapy and are not explainable by...
APBTS - Overview: Adaptor Protein 3 Beta2 (AP3B2) Antibody, Tissue Immunofluorescence Titer, Serum
The differential diagnosis of patients presenting with mixed cerebellar and sensory ataxia and myeloneuropathy Reporting an end titer result from serum specimens
APBCS - Overview: Adaptor Protein 3 Beta2 (AP3B2) Antibody, Cell-Binding Assay, Serum
The differential diagnosis of patients presenting with mixed cerebellar and sensory ataxia and myeloneuropathy Evaluating AP3B2 (adaptor protein 3 beta2)-IgG by cell-binding assay using serum specimens
PC2TS - Overview: Purkinje Cell Cytoplasmic Antibody Type 2 (PCA-2) Titer, Serum
Evaluating patients who present with a subacute neurological disorder of undetermined etiology and have risk factors for lung cancer Reporting an end titer result from serum specimens
AN1TS - Overview: Antineuronal Nuclear Antibody-Type 1 (ANNA-1) Titer, Serum
Diagnosis of paraneoplastic autoimmune neuropathies, encephalomyeloradiculopathies, related neurologic disorders, and intestinal pseudo-obstruction/dysmotility associated with small-cell lung carcinoma Reporting an end titer result from...
CRMTS - Overview: Collapsin Response-Mediator Protein-5 (CRMP-5) Neuronal IgG Titer, Serum
Evaluation of neurological autoimmunity particularly that associated with small-cell lung carcinoma and thymoma Reporting an end titer result from serum specimens
PNEFS - Overview: Neuroimmunology Antibody Follow-up, Serum
Monitoring patients who have previously tested positive for one or more antibodies within the past 5 years in a Mayo Neuroimmunology Laboratory serum evaluation
Site Search
autoimmune-paraneoplastic-dysautonomia-evaluation-algorithm.pdf
© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. Autoimmune/Paraneoplastic Dysautonomia Evaluation Algorithm 05/2024 ■ AP3B2 antibody by CBA ■ AP3B2 antibody by IF titer assay ■ PCA-2 IFA titer■ ANNA-1...
MCL PhenotypeSpecific Testing for Autoimmune and Paraneoplastic Etiologies Poster MC2775455
MCL PhenotypeSpecific Testing Autoimmune Paraneoplastic Etiologies Poster NEUROLOGY PHENOTYPE SPECIFIC TESTING AUTOIMMUNE PARANEOPLASTIC ETIOLOGIES Powered expertise research labs clinical labs Autoimmune
https://news.mayocliniclabs.com/file-ai-antibody-matrix/
The evolution of phenotype-specific antibody testing Autoimmune neurology testing is rapidly evolving, with increasing numbers of clinically relevant biomarkers discovered each year. Mayo Clinic’s Neuroimmunology Laboratory has developed...
Autoimmune Neurology Testing - Insights
Autoimmune neurology is a rapidly evolving subspecialty driven by the discovery that the immune system can target virtually any structure within the
https://news.mayocliniclabs.com/file-autoimmune-neurology-test-ordering-guide/
N EURO LO GY START ORDERING TODAY. PUT YOUR PATIENTS ON THE PATH TO THE RIGHT ANSWER. CALL 800-533-1710 OR VISIT MAYOCLINICLABS.COM/CUSTOMER-SERVICE/CONTACTS. N EURO LO GY © 2024 Mayo Foundation for Medical Education and Research. All...